Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review on Leukemia and Ipsc Technology: Application in Novel Treatment and Future Publisher Pubmed



Maali A1 ; Atashi A2 ; Ghaffari S3 ; Kouchaki R4 ; Abdolmaleki F4 ; Azad M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, Faculty of Allied Medicine, Babol University of Medical Sciences, Babol, Iran
  2. 2. Stem Cells and Tissue Engineering Research Center, Shahroud University of Medical Sciences, Shahroud, Iran
  3. 3. Department of Hematology, Faculty of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Source: Current Stem Cell Research and Therapy Published:2018


Abstract

Leukemia is an uncontrollable growth of hematopoietic cells due to a mutation in DNA followed by cellular dysregulation and one or more chromosomal disorder that generally leads to a clonal abnormality. Theoretical and technical inability in early screening and distinguishing cancer, tumor tolerance to common treatment methods, repeated relapses of cancer after remission phase, heterogeneous chromosomal abnormality, and the side effects of current chemotherapies are some of challenges that we face with leukemia and other malignancies. Induced pluripotent stem cells (iPSC) opened a promising window to a wide range of diseases, including leukemia. Overcoming the barriers in leukemia is possible with iPSC technology. Induced hematopoietic stem cell transplantation (and gene therapy), induced cytotoxic T-lymphocytes and reprogrammed NK cells that strengthen the immune system, miRNAs, modeling approaches, and supportive cares are some aspects of the novel treatment based on iPSC technology. © 2018 Bentham Science Publishers.
Other Related Docs
10. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
11. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
18. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
21. Cancer Cells As a New Source of Induced Pluripotent Stem Cells, Stem Cell Research and Therapy (2022)
25. The Roles of Cd4+ T-Cells in Tumor Immunity, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
26. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
29. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
32. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
33. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
34. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
37. Organoids, Stem Cells in Urology (2020)
39. Cell-Based Therapy for Spinal Muscular Atrophy, Advances in Experimental Medicine and Biology (2020)
42. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
43. Chimeric Antigen Receptor T-Cell Therapy for Melanoma, Expert Review of Clinical Immunology (2021)
44. Crispr/Cas9 Revitalizes Adoptive T-Cell Therapy for Cancer Immunotherapy, Journal of Experimental and Clinical Cancer Research (2021)
45. Stem Cell Therapies for Congenital Heart Disease, Biomedicine and Pharmacotherapy (2016)
46. Tumor Immunology, Clinical Immunology (2022)
49. Engineering the Niche for Hair Regeneration — a Critical Review, Nanomedicine: Nanotechnology# Biology# and Medicine (2019)
50. Application of Nanomaterials in Three-Dimensional Stem Cell Culture, Journal of Cellular Biochemistry (2019)